Home Compare IDXX vs MEDP
Stock Comparison · Industry comparison · Diagnostics & Research

IDEXX Laboratories vs Medpace Holdings: Which Stock Looks Stronger in 2026?

Structurally, IDEXX Laboratories and Medpace are closely matched — neither holds a meaningful edge overall. The remaining gap is narrow enough that the comparison remains open to different readings. In the market, Medpace carries the stronger setup — intact trend against IDEXX Laboratories's broken trend.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

On valuation, the clearer edge sits with Medpace Holdings, Inc., while the broader score remains level.

INDUSTRY COMPARISON

Both operate in: Diagnostics & Research

This comparison is based on industry proximity, not on functional trajectory similarity. IDXX and MEDP share the same industry classification.

For a similarity-based comparison, see how IDEXX Laboratories and Medpace each position within their functional peer groups in AssetNext.

Peer-Relative Score
IDXX
IDEXX Laboratories, Inc.
70
Peer-Score
Signal qualityHigh
vs
MEDP
Medpace Holdings, Inc.
70
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: IDXX vs MEDP Profitability 93 88 Stability 44 40 Valuation 49 57 Growth 94 91 IDXX MEDP
Gap Ranking
#1 Valuation +8
#2 Profitability +5
#3 Stability +4
#4 Growth +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for IDXX and MEDP Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer IDXXMEDP Relative valuation Structural strength

Medpace Holdings, Inc. and IDEXX Laboratories, Inc. look relatively close on structure, but the price setup still leans toward Medpace Holdings, Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both look solid on valuation, though Medpace Holdings, Inc. still holds the stronger peer position.
Valuation — Dominant Gap
IDXX
49
MEDP
57
Gap+8in favour of MEDP

The peer-relative valuation gap is visible, with the stronger side also looking meaningfully cheaper.

What keeps the gap from being one-sided

On the market side, Medpace carries the stronger trend while IDEXX Laboratories's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

Valuation provides the clearer read here, while the broader score remains level.

Explore full peer positioning in AssetNext

Break down the IDXX vs MEDP comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other close comparisons

Explore how IDXX and MEDP each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.